Literature DB >> 30236398

Development of Heart Failure From Transient Atrial Fibrillation Attacks in Responders to Cardiac Resynchronization Therapy.

Ikutaro Nakajima1, Takashi Noda2, Hideaki Kanzaski3, Tsukasa Kamakura3, Mitsuru Wada3, Kohei Ishibashi3, Yuko Inoue3, Koji Miyamoto3, Hideo Okamura3, Satoshi Nagase3, Takeshi Aiba3, Shiro Kamakura3, Teruo Noguchi3, Satoshi Yasuda3, Yoshihiro J Akashi4, Kengo F Kusano3.   

Abstract

OBJECTIVES: This study aimed to clarify the clinical impact of transient atrial fibrillation (AF) attacks themselves and the efficacy of cardiac resynchronization therapy (CRT) in patients with intermittent AF.
BACKGROUND: The benefit of CRT in patients with intermittent AF, especially the effect of the AF attacks themselves, remains unclear.
METHODS: Among our cohort of 269 consecutive CRT patients, we compared the percent of biventricular pacing (BIVP%) and other clinical characteristics between patients with intermittent AF and those with sinus rhythm (SR).
RESULTS: During a median follow-up of 942 days (interquartile range: 379 to 1,464 days) a total of 22 patients, including 59% of CRT responders, developed heart failure (HF) due to a transient AF attack itself, and that accounted for 21% of all HF events. The BIVP% during the AF attacks was significantly lower than that during SR (p < 0.05). When compared to the SR groups, patients with intermittent AF had a significantly higher risk of developing HF or death (hazard ratio: 2.2; 95% confidence interval: 1.3 to 3.8). However, the patients who received a BIVP% of ≥90% during AF attacks were comparable to those with SR (hazard ratio: 1.2; 95% confidence interval: 0.4 to 3.0).
CONCLUSIONS: A substantial number of patients developed HF due to transient AF attacks themselves even in the CRT responders, and the reason was mainly due to the loss of the BIVP%.
Copyright © 2018 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  atrial fibrillation; biventricular pacing rate; cardiac resynchronization therapy; clinical outcome; heart failure

Mesh:

Year:  2018        PMID: 30236398     DOI: 10.1016/j.jacep.2018.06.010

Source DB:  PubMed          Journal:  JACC Clin Electrophysiol        ISSN: 2405-500X


  3 in total

1.  Real-world behavior of CRT pacing using the AdaptivCRT algorithm on patient outcomes: Effect on mortality and atrial fibrillation incidence.

Authors:  Jagmeet P Singh; Yong-Mei Cha; Maurizio Lunati; Eugene S Chung; Shelby Li; Pascal Smeets; David O'Donnell
Journal:  J Cardiovasc Electrophysiol       Date:  2020-02-28

2.  JCS/JHRS 2021 guideline focused update on non-pharmacotherapy of cardiac arrhythmias.

Authors:  Akihiko Nogami; Takashi Kurita; Kengo Kusano; Masahiko Goya; Morio Shoda; Hiroshi Tada; Shigeto Naito; Teiichi Yamane; Masaomi Kimura; Tsuyoshi Shiga; Kyoko Soejima; Takashi Noda; Hiro Yamasaki; Yoshifusa Aizawa; Tohru Ohe; Takeshi Kimura; Shun Kohsaka; Hideo Mitamura
Journal:  J Arrhythm       Date:  2022-01-07

3.  Relationship between device-detected subclinical atrial fibrillation and heart failure in patients with cardiac resynchronization therapy defibrillator.

Authors:  Shuhei Arai; Mitsuharu Kawamura; Toshihiko Gokan; Kosuke Yoshikawa; Ko Ogawa; Akinori Ochi; Yumi Munetsugu; Hiroyuki Ito; Toshiro Shinke
Journal:  Clin Cardiol       Date:  2020-09-29       Impact factor: 2.882

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.